The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
NEW DRUG FOR ALZHEIMER’S. A GROUNDBREAKING ADVANCEMENT TO SLOW THE PROGRESSION, PROGRESSION? EXCUSE ME OF THIS DISEASE. HERE TO EXPLAIN MORE ON WHAT THIS MEANS FOR PATIENTS. IS DOCTOR PETER GLOBUS ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...
The drug will be available to adults with mild cognitive impairments in the early stages of the disease. The company that ...
A new Lilly drug is giving hope to the Alzheimer’s disease community. The drug, Kisunla — also known by the generic name ...
SARASOTA, Fla. (SNN) — The Food and Drug Administration has approved a new Alzheimer’s drug from Eli Lilly. According to Eli ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...